Breast cancer is one of the leading causes of mortality in women worldwide. Both men and women can develop breast cancer. Men, on the other hand, have a 100-fold lower incidence of breast cancer than women. Early identification of breast cancer can help with the therapy and management of the disease. Breast cancer has a good survival percentage if detected early. Early identification of cancer has been proven in studies to boost survival rates by up to 5 years. Mammography, digital tomosynthesis, contrast-enhanced mammography, sonoelastography, magnetic elastography, MRI, diffusion-weighted imaging, nuclear medicine, optical imaging, and microwave imaging are all forms of breast cancer imaging techniques.
What are the recent technological trends?
Recent advances in imaging technologies have revolutionized therapy and its approach to it. The use of imaging technologies such as molecular breast imaging (MBI), positron emission tomography-computed tomography (PET-CT), positron emission mammography (PEM), and cone-beam computed tomography (CBCT), and others to view metabolic information and anatomical properties of organs have grown in importance.
These integrated imaging modalities have improved the quality of breast images, patient comfort, and patient dose. Because of these benefits, manufacturers worldwide are concentrating more on new product releases to increase the sensitivity and accuracy of breast cancer diagnostics. The breast imaging market size has grown considerably over the last decade, owing to increased awareness of the benefits of early breast cancer detection and the high prevalence of breast cancer to reach US$ 10.3 billion by 2030.
Conclusion
Overall, the breast imaging market is expected to continue growing in the coming years, driven by factors such as the increasing prevalence of breast cancer, advances in imaging technology, and a growing emphasis on early detection and screening. As a result, there are significant opportunities for companies operating in this market to develop and market innovative products and services that can help improve patient outcomes and advance the fight against breast cancer.